$10.780
-0.157 (-1.46%)收盘时
HELP 同业对比
In the context of the broader market, HELP competes directly with industry leaders such as SILO and OGEN. With a market capitalization of $807.31M, it holds a leading position in the sector. When comparing efficiency, HELP's gross margin of N/A stands against SILO's -14.77% and OGEN's N/A. Such benchmarking helps identify whether Helus Pharma Inc. is trading at a premium or discount relative to its financial performance.
Cybin Inc 财务表现
The company has reported continuous net losses, with Q4 2026 net income at -46,995,000 CAD and a forward P/E ratio of 0, indicating no earnings expected in the near term.
Financials
FY2022Q4
0.00
Total Revenue
FY2027Q1
YoY:
+99.33%
-49.08M
Operating Profit
FY2027Q1
YoY:
+94.28%
-47.82M
Net Income after Tax
FY2027Q1
YoY:
-17.27%
-0.91
EPS - Diluted
FY2027Q1
YoY:
+25.56%
-37.39M
Free Cash Flow
FY2021Q4
23.10
Gross Profit Margin - %
FY2021Q4
-2.23K
FCF Margin - %
FY2021Q4
-3.73K
Net Margin - %
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。